Literature DB >> 22609537

Age and gender dependent bioavailability of R- and R,S-α-lipoic acid: a pilot study.

Dove J Keith1, Judy A Butler, Brett Bemer, Brian Dixon, Shawn Johnson, Mary Garrard, Daniel L Sudakin, J Mark Christensen, Cliff Pereira, Tory M Hagen.   

Abstract

Lipoic acid (LA) shows promise as a beneficial micronutrient toward improving elder health. Studies using old rats show that (R)-α-LA (R-LA) significantly increases low molecular weight antioxidants that otherwise decline with age. Despite this rationale for benefiting human health, little is known about age-associated alterations in absorption characteristics of LA, or whether the commercially available racemic mixture of LA (R,S-LA) is equally as bioavailable as the naturally occurring R-enantiomer. To address these discrepancies, a pilot study was performed to establish which form of LA is most effectively absorbed in older subjects relative to young volunteers. Young adults (average age=32 years) and older adults (average age=79 years) each received 500 mg of either R- or R,S-LA. Blood samples were collected for 3h after supplementation. After a washout period they were given the other chiral form of LA not originally ingested. Results showed that 2 out of 6 elder males exhibited greater maximal plasma LA and area under the curve for the R-form of LA versus the racemic mixture. The elder subjects also demonstrated a reduced time to reach maximal plasma LA concentration following R-LA supplementation than for the racemic mixture. In contrast, young males had a tendency for increased bioavailability of R,S-LA. Overall, bioavailability for either LA isoform was much more variable between older subjects compared to young adults. Plasma glutathione levels were not altered during the sampling period. Thus subject age, and potential for varied response, should be considered when determining an LA supplementation regimen.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609537      PMCID: PMC4084596          DOI: 10.1016/j.phrs.2012.05.002

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  44 in total

1.  New metabolic pathways of alpha-lipoic acid.

Authors:  H Schupke; R Hempel; G Peter; R Hermann; K Wessel; J Engel; T Kronbach
Journal:  Drug Metab Dispos       Date:  2001-06       Impact factor: 3.922

Review 2.  A role for supplements in optimizing health: the metabolic tune-up.

Authors:  Bruce N Ames
Journal:  Arch Biochem Biophys       Date:  2004-03-01       Impact factor: 4.013

3.  (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo.

Authors:  T M Hagen; V Vinarsky; C M Wehr; B N Ames
Journal:  Antioxid Redox Signal       Date:  2000       Impact factor: 8.401

Review 4.  Fractures in the elderly and vitamin D.

Authors:  J Simon; M Leboff; J Wright; J Glowacki
Journal:  J Nutr Health Aging       Date:  2002       Impact factor: 4.075

5.  (R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria.

Authors:  Jeffrey S Monette; Luis A Gómez; Régis F Moreau; Kevin C Dunn; Judy A Butler; Liam A Finlay; Alexander J Michels; Kate Petersen Shay; Eric J Smith; Tory M Hagen
Journal:  Pharmacol Res       Date:  2010-10-08       Impact factor: 7.658

6.  Effect of DL-alpha-lipoic acid on neural antioxidants in aged rats.

Authors:  P Arivazhagan; C Panneerselvam
Journal:  Pharmacol Res       Date:  2000-09       Impact factor: 7.658

7.  Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid.

Authors:  Jiankang Liu; Elizabeth Head; Afshin M Gharib; Wenjun Yuan; Russell T Ingersoll; Tory M Hagen; Carl W Cotman; Bruce N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 8.  Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress.

Authors:  A R Smith; S V Shenvi; M Widlansky; J H Suh; T M Hagen
Journal:  Curr Med Chem       Date:  2004-05       Impact factor: 4.530

9.  (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis.

Authors:  Jung H Suh; Hong Wang; Rui-Ming Liu; JianKang Liu; Tory M Hagen
Journal:  Arch Biochem Biophys       Date:  2004-03-01       Impact factor: 4.013

10.  Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.

Authors:  Dan Ziegler; Phillip A Low; William J Litchy; Andrew J M Boulton; Aaron I Vinik; Roy Freeman; Rustem Samigullin; Hans Tritschler; Ullrich Munzel; Joachim Maus; Klemens Schütte; Peter J Dyck
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112

View more
  11 in total

1.  Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.

Authors:  Sarah E Fiedler; Vijayshree Yadav; Amelia R Kerns; Catherine Tsang; Sheila Markwardt; Edward Kim; Rebecca Spain; Dennis Bourdette; Sonemany Salinthone
Journal:  Mol Neurobiol       Date:  2017-11-15       Impact factor: 5.590

2.  Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.

Authors:  Kyung Ae Lee; Na Young Lee; Tae Sun Park; Heung Yong Jin
Journal:  Endocrine       Date:  2018-05-07       Impact factor: 3.633

3.  A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations.

Authors:  Gerd Bobe; Alexander J Michels; Wei-Jian Zhang; Jonathan Q Purnell; Clive Woffendin; Cliff Pereira; Joseph A Vita; Nicholas O Thomas; Maret G Traber; Balz Frei; Tory M Hagen
Journal:  J Nutr       Date:  2020-09-01       Impact factor: 4.798

4.  Lipoic acid entrains the hepatic circadian clock and lipid metabolic proteins that have been desynchronized with advanced age.

Authors:  Dove Keith; Liam Finlay; Judy Butler; Luis Gómez; Eric Smith; Régis Moreau; Tory Hagen
Journal:  Biochem Biophys Res Commun       Date:  2014-06-02       Impact factor: 3.575

Review 5.  Lipoic acid. Kinetics and pluripotent biological properties and derivatives.

Authors:  Panagiotis Theodosis-Nobelos; Georgios Papagiouvannis; Paraskevi Tziona; Eleni A Rekka
Journal:  Mol Biol Rep       Date:  2021-08-22       Impact factor: 2.316

Review 6.  Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula
Journal:  Biores Open Access       Date:  2017-12-01

Review 7.  Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.

Authors:  Bahare Salehi; Yakup Berkay Yılmaz; Gizem Antika; Tugba Boyunegmez Tumer; Mohamad Fawzi Mahomoodally; Devina Lobine; Muhammad Akram; Muhammad Riaz; Esra Capanoglu; Farukh Sharopov; Natália Martins; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-08-09

Review 8.  Alpha-Lipoic Acid as a Nutritive Supplement for Humans and Animals: An Overview of Its Use in Dog Food.

Authors:  Reshma M Anthony; Jennifer M MacLeay; Kathy L Gross
Journal:  Animals (Basel)       Date:  2021-05-19       Impact factor: 2.752

Review 9.  Natural Antioxidant Application on Fat Accumulation: Preclinical Evidence.

Authors:  Proshanta Roy; Daniele Tomassoni; Enea Traini; Ilenia Martinelli; Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Francesco Amenta; Seyed Khosrow Tayebati
Journal:  Antioxidants (Basel)       Date:  2021-05-27

10.  Antioxidant and anti-inflammatory effects of selected natural compounds contained in a dietary supplement on two human immortalized keratinocyte lines.

Authors:  Elena Fasano; Simona Serini; Nadia Mondella; Sonia Trombino; Leonardo Celleno; Paola Lanza; Achille Cittadini; Gabriella Calviello
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.